|
|
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss |
| 1R01EY033475-01A1 |
|
NEI |
2022 |
|
|
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa |
| 1UG1EY033286-01 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 3R00EY029330-05S1 |
|
NEI |
2022 |
|
|
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells |
| 4R00EY029011-03 |
|
NEI |
2022 |
|
|
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy |
| 5K08EY029766-04 |
|
NEI |
2022 |
|
|
Computing Core |
| 5P30EY001319-48 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 5R00EY029330-05 |
|
NEI |
2022 |
|
|
Short Term Training in Health Professional Schools |
| 5T35EY007088-37 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center |
| 5UG1EY023204-09 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Data Coordinating Center |
| 5UG1EY023206-09 |
|
NEI |
2022 |